FDA Approved: SUBLOCADE — Supplemental Application (Indivior Inc.)

View source ↗

Summary

The FDA approved a supplemental application for SUBLOCADE (buprenorphine extended-release) submitted by Indivior Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

SUPPL AP for SUBLOCADE (BUPRENORPHINE)